However, others showed that low-dose RT leads to the release of DAMPs (e.g., dsRNA or tumor antigens) from the tumor cells inducing the reprogramming of macrophages towards an iNOS+/M1 phenotype [117,118,119]. The gene discussed is NOS2; the disease is neoplasm.